NCT06440655招募中不适用
A Randomized, Split-head Comparison Study of the Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients : A Pilot Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10
- 试验地点
- 4
- 主要终点
- Trichoscan
研究概览
简要总结
The goal of this clinical trial is to compare between platelet-rich fibrin and platelet-rich plasma in female pattern hair loss . The main question[s] it aims to answer are:
- efficacy between platelet-rich fibrin and platelet-rich plasma
- safety between platelet-rich fibrin and platelet-rich plasma Participants will be divided into 2 side of treatment with composed of
- Platelet rich plasma
- Platelet rich fibrin
详细描述
Subject was treated both platelet-rich fibrin and platelet-rich plasma for 3 times which 1 month interval then will be followed up at 4 months and 6 months after last treatment
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 55 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Age 20-55 years
- •Subject who was diagnosed with Female pattern hair loss in Ludwig Classification 2 (part width 2-4 centimeters) by Dermatologist
排除标准
- •Pregnancy or Lactation subjects
- •Subject with history of platelet dysfunction, low platelet, anemia, cirrhosis, cancer, or immunocompromised host
- •Subject who are active smoking and alcoholism
- •Subject who has dermatitis, scar or infection at intervention area
- •Subject who has history of allergy to anesthesia drug
- •Subject who taking NSAIDs, Hormonal drug, anticoagulants drug
- •Subject who has psychiatric condition diagnosed by psychiatrist
- •Subject who are not allowed to take a photo
结局指标
主要结局
Trichoscan
时间窗: baseline(week0), 4 months after last treatment(week20), 6 months after last treatment(week28)
Average counts and density of hair per 1.5mm\^2
次要结局
- Visual analog scale(baseline(week0), 1 month after first treatment(week4), 1 months after second treatment(week8))
- The 7-point of doctor subjective global assessment(baseline(week0),1 month after first treatment(week4), 1 months after second treatment(week8), 4 months after last treatment(week20), 6 months after last treatment(week28))
- The 7-point of patient subjective global assessment(baseline(week0),1 month after first treatment(week4), 1 months after second treatment(week8), 4 months after last treatment(week20), 6 months after last treatment(week28))
研究者
Rattapon Thuangtong
Associate Professor
Siriraj Hospital
研究点 (4)
Loading locations...
相似试验
已完成
不适用
Platelet Rich Plasma VS Platelet Fibrin Plasma in Treatment of Diabetes Related Wound：a Randomized Controlled TrialDiabetic FootNCT05979584Peking University Third Hospital56
已完成
不适用
Platelet Rich Fibrin in the Treatment of Multiple Gingival RecessionsGingival RecessionNCT02018120Ege University26
已完成
不适用
Treatment of Periodontal Intrabony Defects With A-PRF+ or EMDPeriodontal DiseasesNCT04404374Semmelweis University30
已完成
不适用
Treatment of Periodontal Intrabony Defects With A-PRF or OFDPeriodontal DiseasesNCT04823572Semmelweis University30
已完成
不适用
Management of Cancer Therapy Related Vulvovaginal AtrophyGenitourinary Syndrome of MenopauseNCT05782920Alexandria University45